Monthly Archives: April 2012

16 04-2012
Los Angeles Syndicate of Technology Announces that Portfolio Company, Sanguine BioSciences, has Received Approval to Serve Patients Diagnosed with Multiple Sclerosis, Alzheimer’s Disease, and Parkinso

SANTA MONICA, Calif., April 16, 2012 /PRNewswire/ — Los Angeles Syndicate of Technology, Inc. (OTCQB: LAST), a publicly-traded venture fund and technology incubator, is pleased to announce that its portfolio company, Sanguine BioSciences, Inc. (“Sanguine”), has received approval from...

Read more...
10 04-2012
Los Angeles Syndicate of Technology Announces its Portfolio Company, Sanguine BioSciences, Inc. Makes Major Appointment to Scientific Advisory Board

SANTA MONICA, Calif., April 10, 2012 /PRNewswire/ — Los Angeles Syndicate of Technology, Inc. (OTCQB: LAST), a publicly-traded venture fund and technology incubator, is pleased to announce that its portfolio company, Sanguine BioSciences, Inc. (“Sanguine”), has appointed Dr. Timothy...

Read more...